CIK: 0001601622 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Oct 1, 2018
Total Value ($000): $130,438 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IWF | ishares Rus 1000 Grw ETF | 182,630 | $28,487 | 21.8% | $90.19 | — | ETF | 464287614 |
| IWD | ishares Rus 1000 Val ETF | 202,918 | $25,693 | 19.7% | $97.25 | — | ETF | 464287598 |
| IWP | ishares Rus MD CP Grw ETF | 90,772 | $12,307 | 9.4% | $90.86 | — | ETF | 464287481 |
| IWS | ishares Rus MDCP Val ETF | 130,729 | $11,800 | 9.0% | $70.80 | — | ETF | 464287473 |
| IWN | ishares Rus 2000 Val ETF | 64,869 | $8,628 | 6.6% | $101.86 | — | ETF | 464287630 |
| WIP | SPDR Series Trust DB Int. Gvt. ETF | 161,609 | $8,504 | 6.5% | $21.82 | — | ETF | 78464A490 |
| EFA | ishares MSCI EAFE ETF | 111,674 | $7,593 | 5.8% | $65.80 | — | ETF | 464287465 |
| IWO | ishares Rus 2000 Grw ETF | 32,311 | $6,949 | 5.3% | $140.22 | — | ETF | 464287648 |
| — | REATA PHARMACEUTICALS INC CL A | 60,775 | $4,969 | 3.8% | $21.83 | — | common | 75615P103 |
| VWO | Vanguard Intl Equity Index FTSE EM MKT ETF | 120,297 | $4,932 | 3.8% | $37.44 | — | ETF | 922042858 |
| VNQ | Vanguard Index Fds. REIT ETF | 36,304 | $2,929 | 2.2% | $72.13 | — | ETF | 922908553 |
| TCBI | Texas Capital Bancshares Inc. | 23,693 | $1,958 | 1.5% | $67.45 | +34.5% | common | 88224Q107 |
| — | Powershares DB Cmdty IDX TRA | 87,287 | $1,569 | 1.2% | $15.95 | — | unit ben int | 73935S105 |
| VTI | VANGUARD INDEX FDS VANGUARD TOTAL STK MKT ETF | 10,195 | $1,526 | 1.2% | $105.05 | — | ETF | 922908769 |
| EEM | ishares MSCI EMG MKT ETF | 31,142 | $1,337 | 1.0% | $38.75 | — | ETF | 464287234 |
| CPB | Campbell Soup Co. | 18,447 | $676 | 0.5% | $28.58 | +11.5% | common | 134429109 |
| VXUS | VANGUARD STAR FD TOTAL INTL STOCK INDEX FD ETF SHS | 10,753 | $581 | 0.4% | $44.46 | — | ETF | 921909768 |